FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved a supplemental application for diazepam (generic) from Natco Pharma USA LLC under ANDA210363.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Epilepsy
• Skeletal Muscle Spasm
• Status Epilepticus

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)